Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $176.92 million. The enterprise value is $159.94 million.

Market Cap	176.92M
Enterprise Value	159.94M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.56 million shares outstanding. The number of shares has increased by 0.57% in one year.

Current Share Class	6.56M
Shares Outstanding	6.56M
Shares Change (YoY)	+0.57%
Shares Change (QoQ)	+0.98%
Owned by Insiders (%)	9.11%
Owned by Institutions (%)	37.03%
Float	3.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.22
P/TBV Ratio	1.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.60
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-13.19%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$6.04M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +154.92% in the last 52 weeks. The beta is 2.17, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	2.17
52-Week Price Change	+154.92%
50-Day Moving Average	27.94
200-Day Moving Average	22.98
Relative Strength Index (RSI)	50.47
Average Volume (20 Days)	170,842

Short Selling Information

The latest short interest is 1.04 million, so 15.80% of the outstanding shares have been sold short.

Short Interest	1.04M
Short Previous Month	1.13M
Short % of Shares Out	15.80%
Short % of Float	33.26%
Short Ratio (days to cover)	4.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-54.03M
Pretax Income	-123.32M
Net Income	-84.51M
EBITDA	-51.39M
EBIT	-54.03M
Earnings Per Share (EPS)	-$12.92

Full Income Statement

Balance Sheet

The company has $103.65 million in cash and $86.67 million in debt, giving a net cash position of $16.98 million or $2.59 per share.

Cash & Cash Equivalents	103.65M
Total Debt	86.67M
Net Cash	16.98M
Net Cash Per Share	$2.59
Equity (Book Value)	144.91M
Book Value Per Share	22.09
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.57%
Shareholder Yield	-0.57%
Earnings Yield	-47.77%
FCF Yield	n/a

Analyst Forecast

The average price target for Instil Bio is $119.00, which is 341.23% higher than the current price. The consensus rating is "Buy".

Price Target	$119.00
Price Target Difference	341.23%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a